1 – 10 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Balancing innovation, 'ordre public' and morality in human germline editing : A call for more nuanced approaches in patent law
(2023) p.241-267
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
Mark
Ecosystem effectuation : creating new value through open innovation during a pandemic
- Contribution to journal › Article
-
Mark
Governing, Protecting, and Regulating the Future of Genome Editing : The Significance of ELSPI Perspectives
- Contribution to journal › Scientific review
- 2021
-
Mark
The Role of Patents and Licensing in the Governance of Human Genome Editing: A White Paper
(2021)
- Book/Report › Report
- 2020
-
Mark
Preparing for antimicrobial resistance in the wake of the COVID-19 pandemic: The vision and “social science” mission of the INAMRSS network
(2020)
- Other contribution › Web publication
-
Mark
Social, cultural and economic aspects of antimicrobial resistance
- Contribution to journal › Article
-
Mark
Germany’s digital health reforms in the COVID-19 era: lessons and opportunities for other countries
- Contribution to journal › Article
-
Mark
At the Epicentre of COVID-19 - the Tragic Failure of the Global Supply Chain for Medical Supplies
(2020) In Frontiers in Public Health
- Contribution to journal › Article
-
Mark
Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Data Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield
- Contribution to journal › Article
-
Mark
A qualitative study of biosimilar manufacturer and regulator perceptions on intellectual property and abbreviated approval pathways
- Contribution to journal › Article
